Novo and Lilly are competing to win the GLP-1 pill market as they prepare for Medicare coverage

Written on 06/08/2026

Novo Nordisk and Eli Lilly bring their longtime rivalry to GLP-1 pills and prepare to make their pitch to seniors with Medicare.
Read full article